Dyadic International Inc (DYAI) Stock Analysis

Dyadic International Inc (DYAI) is a publicly traded company in the HEALTHCARE sector. It trades at $0.69, carries a market capitalization of $28.28M. This page summarizes the public market data, fundamentals, and frequently asked questions for DYAI, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.69
• Market Cap: $28.28M
• EPS: $-0.21
• 52-Week High: $1.35
• 52-Week Low: $0.66

Market Sentiment

Dyadic International Inc currently has a Bullish sentiment score of 0.17.

About Dyadic International Inc

Dyadic International, Inc. is a leading biotechnology platform company based in Jupiter, Florida, specializing in the development and production of enzymes and recombinant proteins tailored for diverse applications within the life sciences sector. Utilizing its proprietary C1 cell protein production platform, Dyadic enhances the efficiency and cost-effectiveness of biopharmaceutical manufacturing, catering to the increasing global demand for biologics such as therapeutic proteins and vaccines...

GNG Research Analysis

GNG Research scores Dyadic International Inc (DYAI) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DYAI.

Frequently Asked Questions

Does DYAI pay dividends?

Dyadic International Inc (DYAI) does not currently pay a regular dividend.

What is DYAI's market cap?

Dyadic International Inc (DYAI) has a market capitalization of $28.28M with a current stock price of $0.69.